Welcome to the Xylem second quarter 2017 earnings conference call. At this time, all participants have been placed on listen-only mode, and the floor will be open for your questions following the presentation. I would now like to turn the call over to Matt Latino, Manager of Investor Relations.

Thank you, Angie. Good morning, everyone, and welcome to Xylem's second quarter 2017 earnings conference call. With me today are Chief Executive Officer, Patrick Decker; and Chief Financial Officer, Mark Rajkowski. They will provide their perspective on Xylem's second quarter 2017 results and discuss the full-year outlook for 2017. Following our prepared remarks, we will address questions related to the information covered on the call. I'll ask that you please keep to one question and a follow-up and then return to the queue. As a reminder, this call and our webcast are accompanied by a slide presentation available in the Investors section of our website at www.xyleminc.com. A replay of today's call will be available until midnight on September 2. Please note the replay number is 800-585-8367 and the confirmation code is 41776981. Additionally, the call will be available for playback via the Investors section of our website under the heading Presentations. Please turn to slide number 2. We will make some forward-looking statements on today's call, including references to future events or developments that we anticipate will or may occur in the future. These statements are subject to future risks and uncertainties, such as those factors described in Xylem's most recent Annual Report on Form 10-K and in subsequent reports filed with the SEC. Please note that the company undertakes no obligation to update any forward-looking statements publicly to reflect subsequent events or circumstances, and actual events or results could differ materially from those anticipated. Please turn to slide 3. We have provided you with a summary of our key performance metrics, including both GAAP and non-GAAP metrics. For purposes of today's call, all references will be on an adjusted basis unless otherwise indicated, and non-GAAP financials have been reconciled for you and are included in the Appendix section of the presentation. Now, please turn to slide 4, and I will turn the call over to our CEO, Patrick Decker.

Thanks, Matt. Good morning, everyone. Thanks for joining us to review our second quarter results. Overall, we delivered a solid performance in the quarter, operationally and with healthy margin expansion, and robust order performance which increases our visibility to stronger performance ahead. In the second quarter, we generated top line growth in our base Xylem businesses and in Sensus. We're continuing to execute well, building momentum in the markets we serve. This is particularly notable in several of our emerging market regions. Our progress in driving productivity continues to generate impressive results with another quarter of significant year-over-year gains. The more focused approach we've applied in innovation and technology, partnering with more customers and external institutions, is accelerating our progress towards pilot-ready solutions to meet our customers' challenges. And the integration of our Sensus and Visenti businesses is proceeding well with our teams capturing new opportunities as they collaborate together. The investments we've made in these and other activities are beginning to bear fruit and our second quarter results offer further proof points that our focus and discipline strategy will yield not only the short-term results we expect, but also produce the improved growth we've embedded into our longer-term expectations. So, let me take you through our results from the context of the key priority areas we discussed at our Investor Day early this year. There, we laid out our clear focus on increasing profitable growth, and that begins with driving commercial leadership. In the second quarter, we delivered pro forma organic revenue growth of more than 1% with the base Xylem and Sensus businesses each generating positive results. Our strong growth in orders illustrates the momentum that's building in the business. Globally, we generated an 8% increase in orders in the base Xylem business and double-digit order growth in…

Thanks, Patrick. Let's turn to slide 5. I continue to be pleased with the progress against our strategic initiatives and the commercial momentum we're building. As Patrick detailed, our teams executed well in the second quarter, and their performance, along with improving order growth, positions us strongly as we move into the second half of this year. Overall, revenues were up 25% to $1.2 billion in the second quarter. On a pro forma organic basis, this represents more than 1% growth, with Sensus contributing 2% and the base Xylem business increasing 1%. Foreign exchange reduced revenues by $19 million or about a point. In the base Xylem business, the 1% growth in revenues reflects solid performance in the residential and commercial end markets, up 15% and 3%, respectively, largely driven by strength in the U.S., as well as a 2% increase in our industrial end market. This growth was partially offset by a decline in public utility, which reflects a particularly challenging comparison from the prior-year period, when we delivered 15% growth globally. Regionally, the U.S. was flat year over year, as the strength in residential and commercial was offset by the softness in public utility. Western Europe performance was down 3%, with specific pockets of weakness including the U.K. Emerging markets continued its momentum into the second quarter, when we delivered 7% revenue growth year over year. In the Sensus business, the 2% growth in revenues was in line with the high end of our expectations. This reflected strong double-digit growth across all applications, with the exception of water, where there was a challenging prior-year comparison due to significant distributor stocking of a new product in North America. Moving to operational performance, we increased our adjusted EBITDA margin by 150 basis points to 18.6% in the quarter. This increase…

Thanks, Mark. We delivered a solid performance over the first half of 2017, which strengthened our confidence in our ability to deliver on our financial targets for the year. The changes in our 2017 guidance reflect primarily updates to our foreign currency assumptions. At the top line, we now expect to deliver full-year revenue of $4.65 billion to $4.7 billion. On a pro forma basis, we project organic revenue growth of 3% to 4%, which includes organic growth from the base Xylem business of 2% to 3% and organic growth of 6% to 7% in our Sensus business. Here, we've raised the bottom end of our total company and base Xylem business growth expectations by 1 point. Our Sensus organic growth rate expectations are unchanged. We anticipate achieving $130 million in cost savings for the full year, a 10% year-over-year increase, and we remain on pace to meet that target. Our adjusted operating margin is now forecast to grow in the range of 30 basis points to 80 basis points, excluding roughly 70 basis points of margin dilution from Sensus purchase accounting. This is an increase of 10 basis points in operational margin improvement over our previous guidance. At the bottom line, we now expect to generate earnings per share of $2.30 to $2.40, which excludes integration, restructuring, and realignment costs of approximately $40 million. We've increased our projection for those costs from our previous forecast of $30 million, as we've accelerated certain activities that we now plan to execute in the fourth quarter. Excluding foreign exchange impact, EPS growth is projected to be in the range of 13% to 18%. Finally, as we discussed previously, we expect to deliver free cash flow conversion of at least 110% this year. This contemplates anticipated capital expenditures of approximately $190 million to…

I'll take a few minutes to update you on the seasonal profile of our business, as well as the updates to our 2017 planning assumptions. For the third quarter, based on orders momentum, improving backlogs, and favorable compares, we expect the public utility market to grow mid-single digits on a pro forma basis and our industrial businesses to grow mid-single digits as well. We expect commercial building services to accelerate modestly to the mid- to high single-digit range, and we anticipate moderating growth in residential, up mid- to high single-digits. All in, we anticipate this will result in pro forma organic revenue growth in the range of 4% to 5% in the third quarter. We expect foreign exchange translation to favorably impact revenue by $15 million. Acquisitions are expected to add approximately $230 million to $240 million, with Sensus growing organically at 6% to 7% in the third quarter. As for our third quarter operating margins, we expect margins to be flat to up 20 basis points, excluding the 70-basis-point reduction due to the non-cash amortization of Sensus purchase accounting. There are a couple of items that will put some pressure on our operating margins in the third quarter. The first item is driven by higher cost of batteries that we have secured from alterative suppliers for our Sensus water meters. As we discussed on our last earnings call, an accident in the spring required our previous battery supplier to temporarily close its plant. The team has done a fantastic job identifying alternate suppliers on short notice to largely mitigate this supply issue and minimize customer disruption; however, the costs are substantially higher. Third quarter margins will also be negatively impacted by a significantly higher mix of sales in our treatment business and large project revenues in the emerging markets. Finally, please note the summary of our FX assumptions on this slide, which includes our updated euro guidance assumption at $1.15 from $1.07. This adjustment puts us in line with the July month-to-date average actual rate of $1.15. Aside from our currency assumptions, all other assumptions remain unchanged from our previous guidance. With that, I'll turn the call back over to Patrick for some closing comments.

Thanks, Mark. We've had a solid first half of the year. We're increasingly encouraged by the momentum we see continuing to build in our businesses, and a number of our end markets are showing signs of improvement. Our Sensus integration work remains on track, and we continue to uncover new growth opportunities based on the combined offerings from Xylem and Sensus; and as we do so, we're remaining focused and disciplined to ensure that we execute our near-term plans and continue to deliver on our long-term financial commitments. There is no doubt that we are still in the early days of realizing our strategic ambitions, as we outlined at Investor Day, and we look forward to continuing to develop significant further value creation for our shareholders. Now, operator, we can open up to questions.

The floor is now open for questions. Our first question comes from the line of Ryan Connors of Boenning & Scattergood. Ryan M. Connors - Boenning & Scattergood, Inc.: Great. Thank you. My question is on the public utility market. Obviously tremendous order performance there, but obviously the underlying markets aren't growing that pace, 21% for treatment and 10% for transport. So do you think you're taking any market share there, and can you give us some color about how you analyze the respective contributions of market growth and your own competitive performance?

Sure. Good morning, Ryan. Thanks for the question. So, I'd break it down into the two most meaningful businesses that operate in the public utility sector and that today is our treatment business and our transport business. And I think the answer to your question is different for each of the two. I would say where we saw the significant orders growth in treatment, that really in my view is more attributable to timing of projects being awarded. And so I wouldn't necessarily attribute that to a share gain per se, although we do feel good about our share position in that market. The flip side of that, on the transport side, where we had 10% orders growth in the quarter, again, predominantly attributed to the public utilities sector, that one we do believe is a level of share gain that's really being driven by, one, new product introductions. But also, we've got a very large share position in terms of installed base. And so, as we've seen continued healthy growth in the repair and replacement part of the business, we obviously benefit differentially in that sector. So I would attribute a portion of that to share gain. Ryan M. Connors - Boenning & Scattergood, Inc.: Got it. Okay. And then my other question was on oil and gas and mining, and two questions there. One, how big a contributor was Godwin to the improvement there on the rental side? And then why not more bold in calling a recovery there? It seems like a couple straight quarters of pickup. What would it take to raise your conviction level and get more bullish on that energy market?

Yeah. I think it's a fair question, Ryan. I think that our view, I guess we've been down so long in what is an otherwise a small part of our total revenue base on a business that obviously is one of our most profitable. I think we'd like to see another quarter of continued momentum here to be able to declare a definitive turnaround. Where we saw particularly healthy growth this last quarter was in our indirect channel with our distribution partners, with some restocking there as well as they were deploying capital again, which is obviously a very healthy sign. And so, rig count's going our way, a number of other positive signs there, but we just think it's prudent right now to keep our expectations very level-headed here. Ryan M. Connors - Boenning & Scattergood, Inc.: Okay. And Godwin, any color there?

Yeah, Godwin was the predominant contributor to the growth in that area. Actually, we've got a little bit of softness in our Applied Water business in more of the downstream applications there. That was down a little bit, not much but a little bit, but that was more than offset to drive growth in dewatering. Ryan M. Connors - Boenning & Scattergood, Inc.: Got it. Thanks for your time.

Thank you.

Your next question comes from the line of Deane Dray with RBC Capital Markets.

Thank you. Good morning, everyone.

Good morning, Deane.

Good morning.

Hey, maybe we can start with China. I wasn't expecting to see that kind of growth coming out of the region, up 20% revenues and orders. And maybe part of your answer is what kind of range of products are you seeing, because the facilities we visited in Shanghai seemed to be enamored with your UV treatment, some of your advanced treatment products, so how is the take there? And then also, industry reports have been saying China is really ramping up its focus on non-revenue water, more so than anyone expected. And so, maybe that's part of your growth rate you're seeing and will you use any of the combination with Pure Technologies and Visenti there?

Yeah. Well, thanks, Deane, for the questions. So, a couple of things in there that I'd point to. If you look at our growth in the quarter, it was really outpaced with transport and treatment. We were actually up about 50% year-over-year in that part of the business. Actually our Applied Water business was down about 10%, as we're still lapping some of the weakness there on the industrial commercial building side. So, it really is heavily oriented towards the water sector and the wastewater sector specifically. And that really is being driven by the continued focus, as you well know, on top policy mandate around water and environmental quality, and so we really have continued to see the money flow there. Now, we're also facing some easier comparison last year, but nevertheless, we see good, solid momentum continuing there. To your second point, on the non-revenue water mandate, your industry intel is absolutely spot on. When I was over there just several weeks ago, a number of the water utility CEOs were letting me know that the last five-year mandate has been extended now to include a targeted reduction in non-revenue water, which right now is about 27% as estimated, and they want that number to be down below 10% over the next handful of years. That's an ambitious aim, but certainly it will lead to money flowing. The pilot that we announced that we signed there in Zhenjiang is the first one of those. And so, the good news here is the non-revenue water opportunity is all in front of us as a sector, Deane. And so, it absolutely is going to be the opportunity for us to leverage our partnership between the Xylem Analytics business, Visenti, and Sensus, but also perhaps leveraging the Pure combination as well.

That's great to hear. And then, on Sensus, really interested in hearing anything you can share on this transition to some of the pilot stage of the products. That's what everyone is watching. The extent you can comment like what kinds of applications in these scenarios like watershed monitoring, but some color there would be real helpful.

Sure. I'll give you the color that I can from a competitive standpoint, Deane, in terms of how much detail I share there, but let me speak directionally. So, we've got some pilots that are just about ready to go forward in Asia Pacific, as well as some here in the U.S. with some of the leading water utilities. And we are piloting, quite frankly, different solutions – or we'll be piloting different solutions with each customer. I would describe them as cutting across a few different areas. One is absolutely focusing in on the watershed management and the ability to connect our outdoor water quality monitoring capabilities there. Second would be across the wastewater part of the network in terms of our pumping stations, et cetera, et cetera. And then third, I would say there are, again, the opportunities that I talked about around non-revenue water being a big future play for us. So, those are three of the areas. There are a couple of others that are out there that we're still in the early stages of developing.

Great.

Right now, we're really focused on getting the technologies enabled and making them pilot-ready, then go out and begin to commercialize them.

Good to hear and just last question, I really like seeing this new segmentation with Sensus paired with Analytics. And just – Patrick, if you could just a moment take us through where Analytics focus for growth is from here? A lot of people just think it's immediately a chemical test, but it's much more on the environmental side. So, where and how do you expect to grow the Analytics piece from here?

Yeah, it's a great insight, Deane. It is a business that is very much focusing on environmental quality monitoring, the whole outdoor water management space. The acquisitions that we haven't talked about in a while with HYPACK and Tideland, ocean and coastal monitoring is another opportunity for us in that area. And I think that what we are really excited about right now with the Sensus/Analytics combination is the leverage and power we get out of the combined R&D engineering efforts. And so, you'll see an accelerated ramp and some new product introductions there over the coming – I'd say, over the next year or two. And we've been a little bit stale, quite honestly, in the Analytics business, and I'm encouraged by the opportunity the team sees there now to refresh the portfolio.

Great. Thank you.

Thank you.

Your next question comes from the line of Nathan Jones with Stifel. Nathan H. Jones - Stifel, Nicolaus & Co., Inc.: Good morning everyone.

Good morning.

Hey. Nathan H. Jones - Stifel, Nicolaus & Co., Inc.: Just following up on some of Deane's questions here about the Sensus business and, more directly, on some of the overlap that you can get with Sensus and the legacy portfolio. What kind of level of investment do you see ramping up to? I mean, it looks like a very fertile area for investment. Where are you kind of now? Do you need to ramp up the number of engineers you've got? What kind of investment could the business take where it's at now? How should we think about the trade-off between these investments for growth and delivering margins?

Sure, Nate. Let me start, and then I'll have Mark chime in here as well on some of the numbers. So, at Investor Day, you'll recall we talked about between now and 2020 that you would see an uptick between 100 basis points to 150 basis points of R&D over that timeframe. And as I commented at Investor Day, that was really a proxy for overall investments that we would need to make in the business, whether it ends up in the R&D line, whether it ends up in sales and marketing support as we look at different solutions offerings, but we talked about somewhere between 100 basis points to 150 basis points of margin – or sorry, cost investment that we had embedded in getting to our margin targets over 2020. We'll continue to modulate that and see what is needed. We've made some of that investment in Q2 and we'll make some here in the second half of the year. Our efforts right now have really been building out a center of excellence around systems intelligence in Raleigh-Durham that you would have seen the early stages of. And we'll certainly be adding some sales and marketing resources in targeted areas to really support and drive the deployments over time. But again we'll modulate that as we go along. Mark, do you want to add anything?

Yeah, just a couple of other points. The teams are now at the point where they have a much better understanding of what they really need to deliver and execute. And so, Nate, you will see some ramp-up in the R&D spend levels. To Patrick's point, as we develop those products and solutions, we'll also need additional commercial capabilities to bring them to market. But we're also looking at significantly enhancing what we're bringing in terms of data analytics, data scientists, and we certainly see that as a big opportunity going forward for the company, Software-as-a-Service. And – but we'll also try and do it smartly, so we will be taking advantage of building out our India tech center which can support some of that at a lower cost as well. So, you will bottom line see some ramp in our R&D spend as a percentage of sales as we go through the remainder of this year.

But, Nate, to be clear in what we've said here is, what we're talking about in terms of any level of investment is not different than what we talked about at Investor Day. So, this is not incremental to what we had laid out back in April. Nathan H. Jones - Stifel, Nicolaus & Co., Inc.: I'm wondering, given the pace that this seems to be going at, if there's an opportunity to maybe accelerate some of these investments? I know maybe that will be a little bit of a drag on short-term margins, but are you seeing as you get deeper into this an opportunity to maybe accelerate some of those investments to accelerate growth?

Nate, I think it's a fair observation. I think, right now, it really is more a function of bandwidth, not so much resources per se, but making sure that we're working with specific customers on prototypes and we have to move also at their pace as we develop some of these new solutions and technologies. So, if we see opportunities to accelerate, we'll certainly do that. We wouldn't be constrained financially, quite frankly, we see there being other opportunities on the synergy side as well that we can fund a number of these things. So, it really is not a financial constraint.

Yeah. And, Patrick, to that point, you talked about net synergies, a chunk of those investments are reflected as a reduction to the gross synergies that we're delivering. So, as you said, the more we can deliver in terms of gross cost synergies, it provides more opportunity for further investment. Nathan H. Jones - Stifel, Nicolaus & Co., Inc.: Okay. And then your order numbers are ramping up faster than your revenue outlook. Can you talk about maybe the sequencing of backlog, and how this is setting you up for growth in 2018?

Yeah. Yeah. We've got – we certainly have strong backlog going into the second half. For all of 2017, we're looking at 12% increase year-over-year, but the interesting thing is it's even higher in terms of our backlog going into 2018. And in 2018 and beyond, our year-over-year improvement is 17%. So, it really – and as I highlighted in some of my prepared remarks, we really see that as enabling us to provide really solid second half growth in 2017, but we're even more excited about what we see ahead of us for 2018. Nathan H. Jones - Stifel, Nicolaus & Co., Inc.: Great. Thanks very much.

Thank you, Nathan.

Thanks.

Your next question comes from the line of Brian Lee with Goldman Sachs. Brian Lee - Goldman Sachs & Co.: Hey, guys. Thanks for taking the questions.

Sure. Good morning. Brian Lee - Goldman Sachs & Co.: Good morning. Maybe to follow up on that last one. If I do look at the end market outlook, all the segments here are getting a slight bump versus the organic growth views from the first quarter call except for public utility, but that seems to be an area where you had a couple straight quarters of pretty robust order growth particularly in treatment. So, I'm wondering how should we think about maybe the timing of orders translating to P&L lead time-wise. You mentioned these can be a bit longer. And then maybe how you think about the potential for the outlook for public utility getting upgraded and moving through the second half of 2017 similar to what's happened here with your other end markets?

Sure, yeah. So I would characterize it as such. So, we – our outlook and the expecting to be growing in the 4% to 5% growth range in the back half of the year to get to our base Xylem, kind of, growth here. And if you look at the orders that we delivered in Q2, and we're obviously pleased with that order performance, it was against a rather weak comparison last year, where we were actually down slightly in orders in Q2. So, if you normalize for that, we're kind of in that mid-single digit range, all else equal, and that's pretty much in line with what we're outlooking in terms of organic revenue growth in the second half. And as Mark pointed out, there is some of this order growth that really extends well into 2018 which we view that as an encouraging sign, because obviously as we get closer to the end point of year here, our minds are turning towards the outlook for 2018. And I think the order performance that we've seen here really provides us with even more conviction of the longer-term growth targets that we laid out back in Investor Day.

And I'd add to that, Patrick, to the second part of the question, clearly, there is a – we're going to see a change in trajectory relative to growth in public utility. And we were down through the first half, but certainly, with that order growth, we'd expect to be up low single-digit to mid-single digits for the second half of the year; and on a pro forma basis with Sensus, squarely in the mid-single digit range. Brian Lee - Goldman Sachs & Co.: Okay. Great. That's helpful. And then just second question, maybe a bit more of a housekeeping one. On the EPS guidance update for 2017, it sounds like a bit of additional organic revenue growth for base Xylem and then the new euro ForEx assumption of $1.15. But if I take just the new euro rate and flow it through, I get the entire EPS raise, which is consistent with your commentary. So wondering if there are some offsets to the slightly better organic growth, or if there's something unique about the incrementals on that new revenue? Any clarity there would help. Thanks.

No. I think you've summarized it well relative to the driver of the increase. It is almost entirely FX. We have updated the range. We've narrowed it. We moved up the low point to $2.30, and that's reflective of, really, some of the improved water momentum and what we see as a improved growth profile in the second half. But just about everything in that updated guidance is all FX-related. Brian Lee - Goldman Sachs & Co.: Okay. Thanks, guys.

Yeah.

Your next question comes from the line of Joe Giordano with Cowen. Joseph Giordano - Cowen & Co. LLC: Hey, guys. Good morning.

Good morning, Joe.

Good morning, Joe. Joseph Giordano - Cowen & Co. LLC: So I think with what's going on with Sensus and the synergy opportunities and how attractive that looks, I think part of what gets lost here is the opportunity ahead, just nuts and bolts with the standalone legacy businesses and the cost-out opportunities you have there. So can you kind of update us at where you are year to date versus some of your – whether it's the 2017 kind of internal target or relative to your comments you made at Investor Day on just the core Xylem cost-out opportunity?

Sure, Joe. Let me go first, and then Mark can chime in here. So we feel very good about where we are in terms of the progress on the margin expansion goals that we laid out, not only for total company, but certainly the base business, which is really where the big productivity opportunity lies. And you see that with respect to the continued strong growth in our cost-out activities in Q2 as well as year to date. And when you look at our overall margin expansion goals of up to 80 basis points in the year, that's a good pace for us in terms of margin expansion, particularly given the fact that we're really not seeing a meaningful level of net synergies from Sensus this year. I mean, we're calling for $15 million out of the $50 million over time here, only because the negative synergies hit us on day one, and that obviously minimizes some of the net synergy in year one. You'll see the full-on gross impact of that in 2018. So, if you set that aside, very good progress on the margin side and, quite frankly, we feel that the best is yet to come. We talk about the business simplification work that we're doing, next-generation procurement, we're still early on in terms of our deployment of Lean and Six Sigma. So we remain very confident around the margin expansion goals that we laid out.

Yeah, no, we're tracking very well. And we saw a ramp in the second quarter year over year, and we'll see that continue in through the second half. So we're very confident about our ability to achieve those targets that we've laid out. And as we look at the net synergies from Sensus, that too will really start to ramp, particularly in the fourth quarter of this year. Joseph Giordano - Cowen & Co. LLC: Okay. And then if I shift over, one of the themes that we've been hearing for a while now from a lot of companies is on rising input costs. So if you guys can comment on that. I'm guessing the commentary is very different when you're talking about maybe Flygt and Concertor versus some of the stuff in Applied, but how are you seeing cost inflation and your ability to compensate on pricing?

Yeah. Let me take that one. We're clearly seeing a bit of a ramp in inflation, and it's really driven by commodities. In the first quarter of this year, we saw a 150-basis-point impact year over year. On the second quarter, that did ramp up to 200 basis points, and that was really all commodity based, and we would expect that to continue at that level through the second half of the year, at that elevated level. And it's really being driven by copper, stainless steel. These metals are probably the most significant drivers, but the team understands that. We're pushing hard to drive additional opportunities of savings around procurement to offset some of that. And most importantly, to your question on price, year to date, it's been relatively flat, but there's a lot of movement under that flat result. There are certainly areas in our business where we have opportunity because of competitive advantage, value proposition, to push for price and we're doing that; there's other products that are less advantaged where it's tougher to do that. But we are – this is clearly an area that we're working with our teams to get more aggressive on price because inflation is ramping, it's not going away in the near term, and we just need to be better at getting paid for the value that we're providing our customers in those instances in particular.

Yeah. The good news, Joe, is we've seen this coming for a while now. So we've been working closely between our procurement team and our sales teams to make sure they understand on which product lines it's impacting us and, therefore, where we really want to emphasize going after price. And so, we do expect that benefit to begin to come through in the second half of the year going to next year. And, two, certainly in those areas where we are a definitive market leader, we will behave as such and make sure that we drive pricing in the market. Joseph Giordano - Cowen & Co. LLC: Great. And one just quick clarification; Mark, how much of that $100 million large order in Sensus was actually booked into orders in 2Q?

It was roughly 15% to 20%, just off the top of my head, and that's – really, a lot of that's for next year – a lot of that order will be realized next year.

The key with this one, Joe, is on these large deployments, they're quite complex. They go over a few years of just getting the meters deployed and, obviously, the team work closely with the customer on exactly what their delivery schedule is. And so, the orders that we would have booked in Q2 would have been a small portion of the overall deal, very small portion of the overall deal, and those will be shipping out, quite frankly, later this year into 2018. Joseph Giordano - Cowen & Co. LLC: Perfect. Thanks, guys.

Yeah.

Thank you.

Our next question comes from the line of Jim Giannakouros with Oppenheimer. Jim Giannakouros - Oppenheimer & Co., Inc.: Hey, guys. Good morning.

Hey, Jim.

Good morning, Jim. Jim Giannakouros - Oppenheimer & Co., Inc.: Just tacking on to Joe's question there on that win. Any color on how we should be modeling that deployment? I understand it's weighted to 2018, 2019. Is that equal weight, is it ratable, or is it only weighted in 2018? Is it a net positive for Sensus or do you have projects rolling off that we should be mindful of that kind of offset that, and so they don't necessarily impact that 6% to 7% growth rate that you've guided?

Yeah. So, Jim, the – yeah, and just to clarify for everybody, so the deployment itself will take place. So, the way – it's a two-part contract. So, we got the actual deployment of the meters as well as getting the network built out that takes place over the course of the first two-and-a-half to three years of the contract. And then, we've got a service agreement, software agreement that goes on beyond that, over a 12-year timeframe, so both software and service. And in terms of the modeling, so you're going to see the heavier revenue flow in the first two-and-a-half to three years. That was in embedded in the 6% to 7% growth that we had in the core Sensus business, partly because we do have contracts that potentially roll out, that will be up for bid. But, two, at the time of the acquisition, at the time of Investor Day, we had good line of sight to a number of these large deals that are out there and had – the team had pretty high confidence they were going to win this one. So, that was part of our confidence in committing to at least that 6% to 7% growth over the long range time. Jim Giannakouros - Oppenheimer & Co., Inc.: Understood. Thank you. And one follow-up if I may. Industrial exposure over a 30-year exposure, I understand you're seeing some modest "improvement" overall, but stripping out oil and gas and sticking with that general industrial bucket, where are you seeing increasing activity and where would you call out spending is slow to improve?

Yeah. I think we've certainly seen a modest level of improvement in capital spending in the U.S. industrial sector, as well as in, certainly, Canada had benefited there as well. And as we've said before, we tend to sell into more the general light industrial. So, not so much tied to the actual production activity itself, but as long as the sites are up and running, they will burn through some level of pumps that are there. You'll recall that we saw some unexpected softness there in Q4 and Q1. We had talked about that we would surpass that and things would normalize, and that's very much what we saw happened in Q2 and we expect that to normalize now for the second half. Jim Giannakouros - Oppenheimer & Co., Inc.: Thank you, Patrick.

Thank you.

Your next question comes from the line of John Walsh with Vertical Research.

Hi. Good morning.

Good morning, John.

Hey. So, a lot of ground covered already; just two quick ones here. I guess, a quick modeling question around how to think about Sensus for the full year. A little bit of movement on the acquisition impact and the outlook, but is the low 10% still the right ballpark there from last quarter?

From an operating margin perspective?

Correct.

Yeah. So, Sensus as – on a stand-alone basis, that really hasn't – that outlook has not changed. So, there's nothing in the profile of the mix of our business or investment levels that would suggest that would be any different than what we had outlook previously.

And we're expecting to achieve that 6% to 7% revenue growth for the full year as well.

Got you. And then I'm sure it's still very noisy, but I'd be remiss if I didn't ask, anything out of your customers around infrastructure or any thoughts around there? Obviously a lot of noise coming out of Washington, but any thoughts around that?

Sure. Yeah. So, our view – and we obviously do stay close to this as best we can. In our view, it continues to be that any kind of infrastructure bill would likely be in the 2018, 2019 timeframe as clearly things are kind of shuffling around in D.C. these days. I would say that we wouldn't expect there to be a direct federal funding benefit on the water sector. There might be a little bit there, but we're not counting on that in our outlook. I think where there could be positive impact for our customers would be – as you probably well know, oftentimes the local and state muni budgets when they're under pressure or under constraint, one of the first areas they tend to go after in terms of deferring or delaying is water. And so, obviously, any alleviation of funding pressure for them on other types of infrastructure would obviously help us indirectly from a water standpoint. But we're not seeing a lot right now other than chatter. There's been no real activity that we've seen in terms of projects moving forward that weren't otherwise going, but we'll keep you updated as we go along.

All right. Thank you.

Ladies and gentlemen, we've reached the allotted time for questions. I would now like to turn the call to Patrick Decker for any additional or closing remarks.

Great. Well, again, thanks everybody for joining. Thanks for your continued interest. Appreciate the fact you hung on. We went a little long here today, but appreciate the questions. Safe travels; have a good end of the summer, and we look forward to catching up with you on our next earnings call.

This does conclude the Xylem second quarter 2017 earnings conference call. Please disconnect your lines at this time and have a wonderful day.